company tower banner
Frau Pharma Company Logo

Frau Pharma Carfilzomib

Frau Pharma Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often in combination with other medicines with a similar therapeutic effect.

Benefit Claims (Health): Anti-Cancer Properties, Stimulates Immune System

    Knowde Enhanced TDS

    Identification & Functionality

    Food Ingredients Functions
    Pharma & Nutraceuticals Functions

    Features & Benefits

    Applications & Uses

    Uses

    It is used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous treatments.